blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1741433

EP1741433 - Pharmaceutical composition comprising an androgen [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.09.2013
Database last updated on 21.05.2024
Most recent event   Tooltip24.01.2014Change - lapse in a contracting state
State(s) deleted from list of lapses: CY
published on 26.02.2014  [2014/09]
Applicant(s)For all designated states
FCB I LLC
1105 North Market Street, Suite 1300
Wilmington, DE 19801 / US
[2011/24]
Former [2009/11]For all designated states
CPEX Pharmaceuticals, Inc.
2 Holland Way
Exeter, NH 03833 / US
Former [2007/02]For all designated states
Bentley Pharmaceuticals, Inc.
Bentley Park, 2 Holland Way
Exeter, NH 03833 / US
Inventor(s)01 / Gyurik, Robert
12 Ashbrook Road
Exeter, NH03833 / US
 [2007/02]
Representative(s)Chajmowicz, Marion
Becker & Associés
25, Rue Louis Le Grand
75002 Paris / FR
[N/P]
Former [2012/45]Chajmowicz, Marion
Cabinet Becker et Associés 25, rue Louis le Grand
75002 Paris / FR
Former [2009/30]Chajmowicz, Marion
Cabinet Becker et Associés 25, rue Louis le Grand
75002 Paris / FR
Former [2007/02]Ungria Lopez, Javier, et al
Avda. Ramón y Cajal, 78
28043 Madrid / ES
Application number, filing date06018822.421.04.2003
[2007/02]
Priority number, dateUS20020374103P19.04.2002         Original published format: US 374103 P
[2007/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1741433
Date:10.01.2007
Language:EN
[2007/02]
Type: B1 Patent specification 
No.:EP1741433
Date:07.11.2012
Language:EN
[2012/45]
Search report(s)(Supplementary) European search report - dispatched on:EP13.11.2006
ClassificationIPC:A61K47/32, A61K31/56, A61K9/00
[2012/19]
CPC:
A61K31/568 (EP,KR,US); A61K31/56 (EP,KR,US); A61K31/57 (EP,US);
A61K47/08 (EP,US); A61K47/10 (US); A61K47/22 (US);
A61K47/32 (EP,US); A61K9/0014 (EP,US); A61K9/06 (US);
A61P15/00 (EP); A61P15/08 (EP); A61P15/10 (EP);
A61P19/08 (EP); A61P21/06 (EP); A61P3/00 (EP);
A61P3/06 (EP); A61P5/24 (EP); A61P5/26 (EP) (-)
Former IPC [2007/02]A61K31/56
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   SE,   SK,   TR [2007/02]
TitleGerman:Pharmazeutische Zusammensetzung enthaltend ein Androgen[2012/25]
English:Pharmaceutical composition comprising an androgen[2007/02]
French:Composition pharmaceutique comprenant un androgene[2007/02]
Former [2007/02]Pharmazeutische zusammensetzung enthaltend ein androgen
Examination procedure10.07.2007Examination requested  [2007/34]
14.08.2007Despatch of a communication from the examining division (Time limit: M06)
28.03.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
29.05.2008Reply to a communication from the examining division
11.01.2010Despatch of a communication from the examining division (Time limit: M06)
13.07.2010Reply to a communication from the examining division
21.11.2011Despatch of a communication from the examining division (Time limit: M04)
22.03.2012Reply to a communication from the examining division
25.05.2012Communication of intention to grant the patent
25.09.2012Fee for grant paid
25.09.2012Fee for publishing/printing paid
Parent application(s)   TooltipEP03726373.8  / EP1425019
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030726373) is  07.04.2005
Opposition(s)08.08.2013No opposition filed within time limit [2013/42]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
06.06.2008Request for further processing filed
06.06.2008Full payment received (date of receipt of payment)
Request granted
24.03.2009Decision despatched
Fees paidRenewal fee
08.09.2006Renewal fee patent year 03
08.09.2006Renewal fee patent year 04
27.04.2007Renewal fee patent year 05
28.03.2008Renewal fee patent year 06
01.04.2009Renewal fee patent year 07
25.03.2010Renewal fee patent year 08
12.04.2011Renewal fee patent year 09
28.03.2012Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipDK07.11.2012
[2014/09]
Former [2013/52]CY07.11.2012
DK07.11.2012
Former [2013/34]DK07.11.2012
Documents cited:Search[DA]US5023252  (HSEIH DEAN [US]) [DA] 1-16 * column 14, line 45 - line 60; claim 1 *;
 [A]WO0139754  (PF MEDICAMENT [FR], et al) [A] 1-16* claims 1-21 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.